(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
Live Chart Being Loaded With Signals
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response...
Stats | |
---|---|
Today's Volume | 211 875 |
Average Volume | 297 296 |
Market Cap | 6.83M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.0800 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.270 |
ATR14 | $0.00900 (2.54%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-26 | Pridgen William | Buy | 2 917 | Stock Option (right to buy) |
2024-02-26 | Thomas John C | Buy | 4 167 | Stock Option (right to buy) |
2024-02-26 | Whitley Richard James | Buy | 4 000 | Stock Option (right to buy) |
2024-02-26 | Keefer David R | Buy | 4 709 | Stock Option (right to buy) |
2024-02-26 | Burch Richard Alan | Buy | 2 917 | Stock Option (right to buy) |
INSIDER POWER |
---|
99.86 |
Last 92 transactions |
Buy: 2 833 595 | Sell: 299 106 |
Volume Correlation
Virios Therapeutics, LLC Correlation
10 Most Negative Correlations | |
---|---|
GLPG | -0.857 |
NTUS | -0.823 |
PALT | -0.822 |
SMMT | -0.82 |
IDYA | -0.819 |
TIL | -0.813 |
DSPG | -0.804 |
FFNW | -0.804 |
GAINL | -0.804 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Virios Therapeutics, LLC Correlation - Currency/Commodity
Virios Therapeutics, LLC Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.280 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.280 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.100 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.24 |
Financial Reports:
No articles found.
Virios Therapeutics, LLC
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators